APA (7th ed.) Citation

Y, Z., Y, Q., K, D., & R, C. (2026). Cost effectiveness analysis of PEG-rhG-CSF versus rhG-CSF for primary prophylaxis of chemotherapy induced neutropenia in Chinese patients with non-Hodgkin lymphoma using real world data. Discover oncology, 17(1), . https://doi.org/10.1007/s12672-026-04954-w

Chicago Style (17th ed.) Citation

Y, Zhu, Qu Y, Ding K, and Chen R. "Cost Effectiveness Analysis of PEG-rhG-CSF Versus RhG-CSF for Primary Prophylaxis of Chemotherapy Induced Neutropenia in Chinese Patients with Non-Hodgkin Lymphoma Using Real World Data." Discover Oncology 17, no. 1 (2026). https://doi.org/10.1007/s12672-026-04954-w.

MLA (9th ed.) Citation

Y, Zhu, et al. "Cost Effectiveness Analysis of PEG-rhG-CSF Versus RhG-CSF for Primary Prophylaxis of Chemotherapy Induced Neutropenia in Chinese Patients with Non-Hodgkin Lymphoma Using Real World Data." Discover Oncology, vol. 17, no. 1, 2026, https://doi.org/10.1007/s12672-026-04954-w.